ALOPECIA AREATA(AA)
Clinical trials for ALOPECIA AREATA(AA) explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA(AA) trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA(AA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to regrow hair in alopecia areata patients
Disease control Recruiting nowThis early-stage study tests a new drug called HCW9302 in 30 adults with alopecia areata, a condition causing patchy or complete hair loss. The main goal is to check safety and find the right dose. Researchers will also measure hair regrowth using a standard scalp score.
Matched conditions: ALOPECIA AREATA(AA)
Phase: PHASE1 • Sponsor: HCW Biologics • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
Which drug works best for kids with alopecia? new study aims to find out
Disease control Recruiting nowThis study compares two common drugs, cyclosporine and methotrexate, to treat moderate-to-severe alopecia areata in children aged 2-17. Participants and their parents choose which treatment to try, and doctors measure hair regrowth and quality of life over 9 months. The goal is t…
Matched conditions: ALOPECIA AREATA(AA)
Phase: PHASE4 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug VIS171 tested for lupus, hair loss, and kidney disease
Disease control Recruiting nowThis early-stage trial tests a new drug called VIS171 in 30 people with autoimmune diseases like lupus, alopecia areata, or a kidney condition. The main goal is to check if the drug is safe and tolerable when given as a shot under the skin. Participants will be followed for up to…
Matched conditions: ALOPECIA AREATA(AA)
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New scalp shot aims to regrow hair in patchy baldness
Symptom relief Recruiting nowThis early-stage study tests whether ALD-102, a drug injected into the scalp, is safe and can help regrow hair in people with alopecia areata. About 24 adults with patchy hair loss will receive the drug, a placebo (saline), or no treatment on different scalp areas. The main goal …
Matched conditions: ALOPECIA AREATA(AA)
Phase: PHASE1, PHASE2 • Sponsor: Aldena Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 11:33 UTC